Categories: All postsCannabis

Cresco Labs’ core assets are strong, Beacon Securities says

Cresco Labs (Cresco Labs News, Stock Quote, Chart CSE:CL) acquisition targets are appealing, but investors should not sleep on the company’s core assets.

That’s the message from Beacon Securities analyst Russell Stanley, who on Thursday reiterated his “Buy” rating and one-year price target of $24.00 on the pot stock, representing a return of 91 per cent at the time of publication.

While much attention is paid to Cresco’s acquisition pipeline, we believe the company’s current core markets –Illinois and Pennsylvania – warrant some renewed attention from investors,” the analyst says. “Last month, Illinois became the only state to successfully legalize a comprehensive adult-use program via the legislature (efforts in several other states, notably New York and New Jersey, fell short). CL will thus be allowed to double its dispensary footprint from its current legal maximum of 5, with all 10 locations allowed to serve both the adult-use and medical markets. CL will also be uniquely positioned to build on its 28% share of the wholesale market, given it already has three cultivation/manufacturing facilities operating. In Pennsylvania, one of the fastest growing medical markets in the US, Cresco already has a 25%+ share of the wholesale market, with three retail locations open and another three under license. Finally, management expects to begin wholesale operations in Michigan later this year. MI has the 2nd largest registered patient base in the US (after California), and it recently released emergency (i.e. temporary) rules governing its adultuse market, which should open in early 2020.”

Stanley thinks Cresco will post EBITDA Net NCI of negative $1000 on revenue of $145-million in fiscal 2019. He expects those numbers will improve to EBITDA of positive $209-million on a topline of $732-million the following year.

More Cantech Cannabis

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: cl
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

1 day ago

Is SNAP a buy right now?

He feels the company made forward progress in its recent quarterly results, but Roth MKM analyst Rohit Kulkarni wants to… [Read More]

1 day ago

Bombardier wins price target raise at Desjardins

Following the company's first quarter results, Desjardins analyst Benoit Poirier has raised his price target on Bombardier (Bombardier Stock Quote,… [Read More]

2 days ago

Rogers is an undervalued stock, RBC says

With the integration of Shaw Communications underway, RBC analyst Drew McReynolds says Rogers Communications (Rogers Communications Stock Quote, Chart, News,… [Read More]

3 days ago

Tornado Global Hydrovacs is still a double, Beacon says

Following fourth quarter results he describes as "stronger than expected", Beacon Securities analyst Russell Stanley has raised his price target… [Read More]

3 days ago

Sell your Molson Coors stock, Citi says

Ahead if its first quarter results, Citi analyst Filippo Falorni says there is not much to like about Molson Coors… [Read More]

4 days ago